Does Psychological Stress Affect the Progression of Parkinson’s Disease (N5.002)
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To examine the relationship between psychological stress and Parkinson’s disease progression.
Background: Animal studies suggest that Parkinson’s disease (PD) pathology is negatively affected by stress. More stressful life events may increase the risk of PD. Stress increases damage to dopamine cells and results in more severe parkinsonian symptoms in animal studies. In humans, acute stress can worsen bradykinesia, motor blocking (freezing), and tremor and it is hypothesized that stress may negatively affect dopamine synthesis and release.
Design/Methods: Data from the National Parkinson’s Foundation Quality Improvement Initiative (NPF-QII) was analyzed. The design, data collection, and approach to case-mix adjustment for the study has been described previously (Okun, 2011). All NPF-QII participants able to walk unassisted at baseline were included. A stress proxy score (derived from PDQ-39 and MCSI), a mobility proxy score (derived from iTUG and PDQ-39), and an overall health status score (derived from PDQ-39, falls score, hospital admissions, and cognitive score) were calculated for each subject (n=4,155). Excess stress was identified as positive deviation from the linear regression between the stress proxy score and a normalized combination of the other outcomes measured (motor, cognitive, falls, and other PDQ-39 domains). This “excess stress” (ES) score reflects the emotional stress above that typically resulting from disease severity or overall health.
Results: 1) The stress proxy score predicts mortality but the ES score does not (p<0.001). 2) high baseline stress proxy score predicts worsening mobility on follow-up (p<0.001; R2=0.026), and high ES also predicts worsening mobility (p=0.0014; R2=0.0025).
Conclusions: Stress may be a modifiable risk factor for disease progression.
Study Supported by: National Parkinson Foundation
Disclosure: Dr. Hiller has nothing to disclose. Dr. Quinn has received personal compensation for activities with Novartis as a speaker. Dr. Schmidt has nothing to disclose.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan
Related Articles
- No related articles found.